Published in J Nutr Biochem on September 12, 2007
Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders. Exp Gerontol (2009) 1.59
Metabolic syndrome, aging and involvement of oxidative stress. Aging Dis (2015) 1.22
Freeze-dried strawberry powder improves lipid profile and lipid peroxidation in women with metabolic syndrome: baseline and post intervention effects. Nutr J (2009) 1.13
Exercise in the metabolic syndrome. Oxid Med Cell Longev (2012) 1.11
Upregulation of hemoglobin expression by oxidative stress in hepatocytes and its implication in nonalcoholic steatohepatitis. PLoS One (2011) 1.08
Obstructive sleep apnea, inflammation, and the metabolic syndrome. Metab Syndr Relat Disord (2009) 1.08
Oxidative stress in obesity: a critical component in human diseases. Int J Mol Sci (2014) 1.08
GSTM1, GSTT1, and GSTP1 polymorphisms and associations between air pollutants and markers of insulin resistance in elderly Koreans. Environ Health Perspect (2012) 1.07
A subset of dysregulated metabolic and survival genes is associated with severity of hepatic steatosis in obese Zucker rats. J Lipid Res (2009) 1.01
Effect of keishibukuryogan on endothelial function in patients with at least one component of the diagnostic criteria for metabolic syndrome: a controlled clinical trial with crossover design. Evid Based Complement Alternat Med (2012) 0.98
High fat diet-induced non alcoholic fatty liver disease in rats is associated with hyperhomocysteinemia caused by down regulation of the transsulphuration pathway. Lipids Health Dis (2011) 0.98
Acute changes in heart rate variability in subjects with diabetes following a highway traffic exposure. J Occup Environ Med (2010) 0.98
GLP1-derived nonapeptide GLP1(28-36)amide protects pancreatic β-cells from glucolipotoxicity. J Endocrinol (2012) 0.95
Oxidative stress is associated with the number of components of metabolic syndrome: LIPGENE study. Exp Mol Med (2013) 0.95
Diethylhexyl phthalates is associated with insulin resistance via oxidative stress in the elderly: a panel study. PLoS One (2013) 0.93
How Much Weight Loss is Effective on Nonalcoholic Fatty Liver Disease? Hepat Mon (2013) 0.88
Thrombotic markers in metabolic syndrome subjects exposed to diesel exhaust. Inhal Toxicol (2008) 0.87
Longitudinal associations between post-traumatic stress disorder and metabolic syndrome severity. Psychol Med (2016) 0.87
Advanced glycation end-products: modifiable environmental factors profoundly mediate insulin resistance. J Clin Biochem Nutr (2015) 0.87
Cardiovascular autonomic dysfunction and oxidative stress induced by fructose overload in an experimental model of hypertension and menopause. BMC Cardiovasc Disord (2014) 0.86
Adipose tissue-specific dysregulation of angiotensinogen by oxidative stress in obesity. Metabolism (2010) 0.85
Effects of Açai (Euterpe oleracea Mart.) berry preparation on metabolic parameters in a healthy overweight population: a pilot study. Nutr J (2011) 0.85
Posttraumatic Stress Disorder as a Catalyst for the Association Between Metabolic Syndrome and Reduced Cortical Thickness. Biol Psychiatry (2015) 0.84
Metabolic syndrome and skin: psoriasis and beyond. Indian J Dermatol (2013) 0.83
Intake of red wine in different meals modulates oxidized LDL level, oxidative and inflammatory gene expression in healthy people: a randomized crossover trial. Oxid Med Cell Longev (2014) 0.83
Oxidative stress status accompanying diabetic bladder cystopathy results in the activation of protein degradation pathways. BJU Int (2010) 0.83
Determinants of the transition from a cardiometabolic normal to abnormal overweight/obese phenotype in a Spanish population. Eur J Nutr (2013) 0.83
Mitochondrial oxidative stress alters a pathway in Caenorhabditis elegans strongly resembling that of bile acid biosynthesis and secretion in vertebrates. PLoS Genet (2012) 0.82
Can red yeast rice and olive extract improve lipid profile and cardiovascular risk in metabolic syndrome?: A double blind, placebo controlled randomized trial. BMC Complement Altern Med (2015) 0.82
Dietary total antioxidant capacity and the occurrence of metabolic syndrome and its components after a 3-year follow-up in adults: Tehran Lipid and Glucose Study. Nutr Metab (Lond) (2012) 0.81
X-ray crystallographic analysis of adipocyte fatty acid binding protein (aP2) modified with 4-hydroxy-2-nonenal. Protein Sci (2010) 0.79
The Effects of Long-Term, Low-Level Exposure to Monocyclic Aromatic Hydrocarbons on Worker's Insulin Resistance. Saf Health Work (2011) 0.79
A silybin-phospholipids complex counteracts rat fatty liver degeneration and mitochondrial oxidative changes. World J Gastroenterol (2013) 0.79
The skin function: a factor of anti-metabolic syndrome. Diabetol Metab Syndr (2012) 0.78
Utilization of dietary glucose in the metabolic syndrome. Nutr Metab (Lond) (2011) 0.78
Independent positive association of plasma β-carotene concentrations with adiponectin among non-diabetic obese subjects. Eur J Nutr (2014) 0.78
The impact of mitochondrial oxidative stress on bile acid-like molecules in C. elegans provides a new perspective on human metabolic diseases. Worm (2013) 0.78
GLP-1(32-36)amide Pentapeptide Increases Basal Energy Expenditure and Inhibits Weight Gain in Obese Mice. Diabetes (2015) 0.78
Increased inflammation, reduced plasma phospholipid eicosapentaenoic acid and reduced antioxidant potential of treated hypertensive patients with metabolic syndrome. Yonsei Med J (2009) 0.77
The effects of hazardous chemical exposure on cardiovascular disease in chemical products manufacturing workers. Toxicol Res (2012) 0.77
Oxidatively modified forms of albumin in patients with risk factors of metabolic syndrome. J Endocrinol Invest (2014) 0.77
Oxidative status imbalance in patients with metabolic syndrome: role of the myeloperoxidase/hydrogen peroxide axis. Oxid Med Cell Longev (2014) 0.77
Coenzyme Q metabolism is disturbed in high fat diet-induced non-alcoholic fatty liver disease in rats. Int J Mol Sci (2012) 0.76
Effects of concurrent training on oxidative stress and insulin resistance in obese individuals. Oxid Med Cell Longev (2015) 0.76
Effects of Tithonia diversifolia (Hemsl.) A. Gray extract on adipocyte differentiation of human mesenchymal stem cells. PLoS One (2015) 0.76
Nutritional Cues Tie Living Organisms to Their Environment and Its Sustainability. Front Nutr (2016) 0.75
The Emerging Role of Disturbed CoQ Metabolism in Nonalcoholic Fatty Liver Disease Development and Progression. Nutrients (2015) 0.75
Fructose-Rich Diet Affects Mitochondrial DNA Damage and Repair in Rats. Nutrients (2017) 0.75
Oxidative Stress Function in Women over 40 Years of Age, Considering Their Lifestyle. Front Endocrinol (Lausanne) (2017) 0.75
Oxidative stress, point-of-care test, and metabolic syndrome. Korean J Intern Med (2014) 0.75
Effects of prenatal micronutrient and early food supplementation on metabolic status of the offspring at 4.5 years of age. The MINIMat randomized trial in rural Bangladesh. Int J Epidemiol (2016) 0.75
Effects of Hormone Therapy on Oxidative Stress in Postmenopausal Women with Metabolic Syndrome. Int J Mol Sci (2016) 0.75
Association of glutathione S-transferases M1 and T1 gene polymorphisms with the risk of metabolic syndrome in an Iranian population. Adv Biomed Res (2016) 0.75
The modifying effect of vitamin C on the association between perfluorinated compounds and insulin resistance in the Korean elderly: a double-blind, randomized, placebo-controlled crossover trial. Eur J Nutr (2015) 0.75
The Protective Effect of Antioxidants Consumption on Diabetes and Vascular Complications. Diseases (2016) 0.75
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab (2005) 9.14
Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J Clin Invest (2004) 4.65
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat Genet (2010) 3.15
Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. Proc Natl Acad Sci U S A (2006) 3.05
Cholesterol gallstone disease. Lancet (2006) 2.83
REV-ERBalpha participates in circadian SREBP signaling and bile acid homeostasis. PLoS Biol (2009) 2.76
Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis. Gastroenterology (2011) 2.67
Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease. Gut (2011) 2.57
Identification of a hormonal basis for gallbladder filling. Nat Med (2006) 2.03
Concomitant, sequential, and hybrid therapy for H. pylori eradication: a pilot study. Clin Res Hepatol Gastroenterol (2013) 1.70
Prevention of spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice by intestinal-specific farnesoid X receptor reactivation. Hepatology (2014) 1.68
Nuclear bile acid receptor FXR protects against intestinal tumorigenesis. Cancer Res (2008) 1.61
Ribavirin-induced anemia: mechanisms, risk factors and related targets for future research. Curr Med Chem (2006) 1.60
Expression of ABCG5 and ABCG8 is required for regulation of biliary cholesterol secretion. J Biol Chem (2004) 1.57
Deciphering the nuclear bile acid receptor FXR paradigm. Nucl Recept Signal (2010) 1.53
Esomeprazole-induced central fever with severe myalgia. Ann Pharmacother (2005) 1.41
Nonalcoholic fatty liver disease. Best Pract Res Clin Gastroenterol (2010) 1.35
FXR agonists and FGF15 reduce fecal bile acid excretion in a mouse model of bile acid malabsorption. J Lipid Res (2007) 1.31
Peroxisome proliferator-activated receptor-gamma coactivator 1-alpha (PGC1alpha) is a metabolic regulator of intestinal epithelial cell fate. Proc Natl Acad Sci U S A (2011) 1.23
Coordinate regulation of gallbladder motor function in the gut-liver axis. Hepatology (2008) 1.22
Intestinal specific LXR activation stimulates reverse cholesterol transport and protects from atherosclerosis. Cell Metab (2010) 1.20
Activation of LXRs prevents bile acid toxicity and cholestasis in female mice. Hepatology (2007) 1.20
Systemic oxidative alterations are associated with visceral adiposity and liver steatosis in patients with metabolic syndrome. J Nutr (2006) 1.17
Primary sclerosing cholangitis: updates in diagnosis and therapy. World J Gastroenterol (2005) 1.16
Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones. Gastroenterology (2008) 1.16
New insights into the molecular mechanisms underlying effects of estrogen on cholesterol gallstone formation. Biochim Biophys Acta (2009) 1.13
Significant factors associated with fatal outcome in emergency open surgery for perforated peptic ulcer. World J Gastroenterol (2003) 1.09
Down-regulation of the LXR transcriptome provides the requisite cholesterol levels to proliferating hepatocytes. Hepatology (2010) 1.09
The intestinal nuclear receptor signature with epithelial localization patterns and expression modulation in tumors. Gastroenterology (2009) 1.08
Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial. Free Radic Biol Med (2012) 1.07
Mitochondrial dysfunction in rat with nonalcoholic fatty liver Involvement of complex I, reactive oxygen species and cardiolipin. Biochim Biophys Acta (2007) 1.05
The reduced tolerance of rat fatty liver to ischemia reperfusion is associated with mitochondrial oxidative injury. J Surg Res (2005) 1.05
Nonalcoholic steatohepatitis: recent advances from experimental models to clinical management. Clin Biochem (2005) 1.03
Pan-enteric dysmotility, impaired quality of life and alexithymia in a large group of patients meeting ROME II criteria for irritable bowel syndrome. World J Gastroenterol (2003) 1.03
Role of mitochondria in nonalcoholic fatty liver disease--from origin to propagation. Clin Biochem (2012) 1.03
Lipid-sensing nuclear receptors in the pathophysiology and treatment of the metabolic syndrome. Wiley Interdiscip Rev Syst Biol Med (2011) 1.02
Bile acids and colon cancer: Solving the puzzle with nuclear receptors. Trends Mol Med (2011) 1.01
Nuclear bile acid receptor FXR as pharmacological target: are we there yet? FEBS Lett (2006) 1.01
Gallbladder histopathology during murine gallstone formation: relation to motility and concentrating function. J Lipid Res (2005) 1.00
Liver X receptors inhibit proliferation of human colorectal cancer cells and growth of intestinal tumors in mice. Gastroenterology (2013) 1.00
Emerging role of fibroblast growth factors 15/19 and 21 as metabolic integrators in the liver. Hepatology (2012) 1.00
Microbiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options. Scand J Gastroenterol (2013) 0.99
The insulin receptor substrate 1 (IRS1) in intestinal epithelial differentiation and in colorectal cancer. PLoS One (2012) 0.98
Molecular pathophysiology and physical chemistry of cholesterol gallstones. Front Biosci (2008) 0.97
Dissecting the genetic heterogeneity of gallbladder stone formation. Semin Liver Dis (2011) 0.97
The Vibrio cholerae cytolysin promotes chloride secretion from intact human intestinal mucosa. PLoS One (2009) 0.96
PNPLA3-associated steatohepatitis: toward a gene-based classification of fatty liver disease. Semin Liver Dis (2013) 0.96
Biochemical mechanisms in drug-induced liver injury: certainties and doubts. World J Gastroenterol (2009) 0.95
Intestinal mucosal damage caused by non-steroidal anti-inflammatory drugs: role of bile salts. Clin Biochem (2007) 0.94
Present and future therapeutic strategies in non-alcoholic fatty liver disease. Expert Opin Ther Targets (2007) 0.94
Effect of gallbladder hypomotility on cholesterol crystallization and growth in CCK-deficient mice. Biochim Biophys Acta (2009) 0.93
Mitochondria in chronic liver disease. Curr Drug Targets (2011) 0.93
Steatosis in the liver. Compr Physiol (2013) 0.93
Managing nonalcoholic fatty liver disease: recommendations for family physicians. Can Fam Physician (2007) 0.93
Rendu-Osler-Weber disease: experience with 56 patients. Ann Ital Med Int (2002) 0.91
Liver breath tests non-invasively predict higher stages of non-alcoholic steatohepatitis. Clin Sci (Lond) (2006) 0.91
Long-term functional assessment of antegrade colonic enema for combined incontinence and constipation using a modified Marsh and Kiff technique. Dis Colon Rectum (2007) 0.90
Master regulation of bile acid and xenobiotic metabolism via the FXR, PXR and CAR trio. Front Biosci (Landmark Ed) (2009) 0.90
Current pharmacological treatment of nonalcoholic fatty liver. Curr Med Chem (2006) 0.90
Ezetimibe: its novel effects on the prevention and the treatment of cholesterol gallstones and nonalcoholic Fatty liver disease. J Lipids (2011) 0.90
Targets for current pharmacologic therapy in cholesterol gallstone disease. Gastroenterol Clin North Am (2010) 0.90
Basal and bevacizumab-based therapy-induced changes of lactate dehydrogenases and fibrinogen levels and clinical outcome of previously untreated metastatic colorectal cancer patients: a multicentric retrospective analysis. Expert Opin Biol Ther (2014) 0.89
Glutathione peroxidase, thioredoxin, and membrane protein changes in erythrocytes predict ribavirin-induced anemia. Clin Pharmacol Ther (2005) 0.89
Intestinal permeability in patients with chronic liver diseases: Its relationship with the aetiology and the entity of liver damage. Dig Liver Dis (2009) 0.89
Management of liver cirrhosis between primary care and specialists. World J Gastroenterol (2011) 0.89
Does mediastinal extension of the goiter increase morbidity of total thyroidectomy? A multicenter study of 19,662 patients. Ann Surg Oncol (2011) 0.88
Contractility in vitro and mitochondrial response in small and large rabbit bowel after anastomosis. World J Surg (2002) 0.87
A pleiotropic role for the orphan nuclear receptor small heterodimer partner in lipid homeostasis and metabolic pathways. J Lipids (2012) 0.87
Non-alcoholic fatty liver disease in the metabolic syndrome. Curr Pharm Des (2007) 0.87
Total thyroidectomy is improved by loupe magnification. Microsurgery (2004) 0.87
Atherosclerosis: lessons from LXR and the intestine. Trends Endocrinol Metab (2012) 0.87
Avoiding drug interactions: here's help. J Fam Pract (2010) 0.87
Familial mediterranean fever: a fascinating model of inherited autoinflammatory disorder. Eur J Clin Invest (2013) 0.87